These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 10422270)

  • 41. Pulmonary surfactant obtained from starved rats enhances phagocytosis of alveolar macrophages.
    Sakai K; Ueyama A; Kishino Y
    Cell Mol Biol; 1991; 37(4):475-80. PubMed ID: 1934019
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antibodies to Cryptococcus neoformans glucuronoxylomannan enhance antifungal activity of murine macrophages.
    Mukherjee S; Lee SC; Casadevall A
    Infect Immun; 1995 Feb; 63(2):573-9. PubMed ID: 7822024
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Opsonic activities of surfactant proteins A and D in phagocytosis of gram-negative bacteria by alveolar macrophages.
    Pikaar JC; Voorhout WF; van Golde LM; Verhoef J; Van Strijp JA; van Iwaarden JF
    J Infect Dis; 1995 Aug; 172(2):481-9. PubMed ID: 7622892
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Interferon-gamma reduces the capacity of human alveolar macrophages to inhibit growth of Cryptococcus neoformans in vitro.
    Reardon CC; Kim SJ; Wagner RP; Kornfeld H
    Am J Respir Cell Mol Biol; 1996 Dec; 15(6):711-5. PubMed ID: 8969264
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Interleukin-17 is not required for classical macrophage activation in a pulmonary mouse model of Cryptococcus neoformans infection.
    Hardison SE; Wozniak KL; Kolls JK; Wormley FL
    Infect Immun; 2010 Dec; 78(12):5341-51. PubMed ID: 20921149
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Effects of low concentrations of 3-carene on alveolar macrophages in vitro.
    Johansson A; Lundborg M
    Toxicology; 1997 Jun; 120(2):99-104. PubMed ID: 9184196
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Laccase protects Cryptococcus neoformans from antifungal activity of alveolar macrophages.
    Liu L; Tewari RP; Williamson PR
    Infect Immun; 1999 Nov; 67(11):6034-9. PubMed ID: 10531264
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Immunology of infection caused by Cryptococcus neoformans.
    Wormley FL; Perfect JR
    Methods Mol Med; 2005; 118():193-8. PubMed ID: 15888944
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [The defensive role of human pulmonary alveolar macrophages and polymorphonuclear leukocytes against a strongly or weakly virulent strains of Cryptococcus neoformans].
    Tabeta H; Kohno N; Kamei K; Honda A; Unno H; Nagao K; Yamaguchi T; Miyaji M
    Nihon Kyobu Shikkan Gakkai Zasshi; 1991 Sep; 29(9):1174-9. PubMed ID: 1753544
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Analysis of cell cycle and replication of mouse macrophages after in vivo and in vitro Cryptococcus neoformans infection using laser scanning cytometry.
    Coelho C; Tesfa L; Zhang J; Rivera J; Gonçalves T; Casadevall A
    Infect Immun; 2012 Apr; 80(4):1467-78. PubMed ID: 22252872
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Activation and binding of opsonic fragments of C3 on encapsulated Cryptococcus neoformans by using an alternative complement pathway reconstituted from six isolated proteins.
    Kozel TR; Wilson MA; Pfrommer GS; Schlageter AM
    Infect Immun; 1989 Jul; 57(7):1922-7. PubMed ID: 2525113
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Paradoxical role of capsule in murine bronchoalveolar macrophage-mediated killing of Cryptococcus neoformans.
    Levitz SM; DiBenedetto DJ
    J Immunol; 1989 Jan; 142(2):659-65. PubMed ID: 2521352
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Particle opsonization and lung macrophage cytokine response. In vitro and in vivo analysis.
    Kobzik L; Huang S; Paulauskis JD; Godleski JJ
    J Immunol; 1993 Sep; 151(5):2753-9. PubMed ID: 8360489
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Triggering effects of opsonized-IgG antibody on the superoxide release in the phagosome and phagosome-lysosome fusion by pulmonary alveolar macrophages in rabbits.
    Suga M; Ando M; Tanaka F; Araki S
    J Clin Lab Immunol; 1990 Oct; 33(2):55-9. PubMed ID: 1967066
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Role of the capsule in phagocytosis of Cryptococcus neoformans.
    Kozel TR; Pfrommer GS; Guerlain AS; Highison BA; Highison GJ
    Rev Infect Dis; 1988; 10 Suppl 2():S436-9. PubMed ID: 3055212
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Binding of unopsonized Cryptococcus neoformans by human bronchoalveolar macrophages: inhibition by a large-molecular-size serum component.
    Levitz SM; Tabuni A; Wagner R; Kornfeld H; Smail EH
    J Infect Dis; 1992 Oct; 166(4):866-73. PubMed ID: 1527424
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Pulmonary surfactant protein A enhances the host-defense mechanism of rat alveolar macrophages.
    van Iwaarden F; Welmers B; Verhoef J; Haagsman HP; van Golde LM
    Am J Respir Cell Mol Biol; 1990 Jan; 2(1):91-8. PubMed ID: 2306370
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Effect of macrophage colony-stimulating factor on anticryptococcal activity of bronchoalveolar macrophages: synergy with fluconazole for killing.
    Brummer E; Nassar F; Stevens DA
    Antimicrob Agents Chemother; 1994 Sep; 38(9):2158-61. PubMed ID: 7811035
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Naïve B cells reduce fungal dissemination in Cryptococcus neoformans infected Rag1
    Dufaud C; Rivera J; Rohatgi S; Pirofski LA
    Virulence; 2018 Jan; 9(1):173-184. PubMed ID: 28837391
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Lung surfactant protein A (SP-A) activates a phosphoinositide/calcium signaling pathway in alveolar macrophages.
    Ohmer-Schröck D; Schlatterer C; Plattner H; Schlepper-Schäfer J
    J Cell Sci; 1995 Dec; 108 ( Pt 12)():3695-702. PubMed ID: 8719876
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.